Year: 2020

1. Deltagere i Selskapets RSU program har 13. november 2020 fått frigitt totalt 145 070 RSUer. Som følge av frigivelsen vil 145 070 aksjer overføres fra selskapets beholdning av egne aksjer. Etter transaksjonen har Selskapet 232 071 egne aksjer.2. RSUer frigitt til primærinnsidere 13. november 2020:– Arthur Wisniewski har mottatt 1 416 aksjer i Selskapet– Eva Haugen har mottatt 1 772 aksjer i Selskapet– Ståle Eide (nærstående part av primærinnsider) har mottatt 1 412 aksjer i Selskapet– Frode Arntsen har mottatt 2 826 aksjer i Selskapet– Håkon Husby har mottatt 207 aksjer i Selskapet– Roger Bekken har mottatt 2 561 aksjer i Selskapet– Runar Sivertsen har mottatt 1 103 aksjer i Selskapet– Tonette Bjørgård har mottatt 1 772 aksjer i Selskapet– Trine Sæther Romuld har mottatt 669 aksjer...

13 November 2020LEI: 2138003QW2ZAYZODBU23WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE S&P 500 VIX SHORT-TERM FUTURES 2.25X DAILY LEVERAGED SECURITIES(ISIN: IE00BYTYHQ58)(THE “AFFECTED SECURITIES”)PROPOSALS FOR THE AMENDMENT OF THEPRODUCT LEVERAGE FACTOR OF THE AFFECTED SECURITIES AND CONSEQUENTIAL OTHER CHANGESRESULTS OF MEETING OF THE ETP SECURITYHOLDERSWisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”) wishes to announce that further to announcements on 6 October 2020, and 29 October 2020 in relation to meetings of the holders of the Affected Securities, notice is hereby given that at the adjourned meetings held on 13 November 2020 the Extraordinary Resolution set out in the Notice of Meeting has not passed by the requisite majority.For...

Pursuant to the law of 2 May 2007 on the disclosure of significant participations and the introduction of a 3% statutory declaration threshold in the articles of association of Befimmo SA, Befimmo announces that it has received, on 11 November 2020, a transparency declaration from Norges Bank. This declaration was done following the upward crossing of the declaration thresholds of 3% on 9 November 2020.AttachmentBefimmo SA – Transparency declaration Norges – 13.11.2020 – FINAL

Conformément à la loi du 2 mai 2007 relative à la publicité de participations importantes et à l’introduction dans les statuts de Befimmo SA d’un seuil statutaire de déclaration de 3%, Befimmo annonce avoir reçu, le 11 novembre 2020, une déclaration de transparence de la part de Norges Bank. Cette déclaration est faite suite au franchissement, le 9 novembre 2020, du seuil de déclaration de 3% vers le haut.Pièce jointeBefimmo SA – Déclaration de transparence Norges – 13.11.2020 – FINAL

Conform de wet van 2 mei 2007 betreffende de openbaarmaking van belangrijke deelnemingen en de invoering van een statutaire verklaringsdrempel van 3% in de statuten van Befimmo NV, deelt Befimmo mee een transparantieverklaring te hebben ontvangen van Norges Bank op 11 november 2020. Met deze verklaring meldt Norges Bank dat haar participatie in Befimmo op 9 november 2020 de verklaringsdrempel van 3% heeft overschreden.BijlageBefimmo NV – Transparantieverklaring Norges – 13.11.2020 – FINAL

BOISE, Idaho, Nov. 13, 2020 (GLOBE NEWSWIRE) — PCS Edventures!, Inc., (PCSV) a leading provider of K-12 Science, Technology, Engineering and Mathematics (STEM) education programs and drone products, today announced unaudited results of operations for its second quarter of Fiscal Year 2021 which ended on September 30, 2020.Revenue was $0.39 million, which was down 54% from the revenue generated in the same period last year. Net income was ($0.21 million) compared to $0.58 million for the same period last year.Michael Bledsoe, President, commented, “While schools are starting to cautiously go back to in-person learning, the classroom environment has changed. In more instances than not, school supplies and enrichment materials are no longer shared, sometimes by state mandate, with the intention of reducing the risk of COVID-19 transmission....

Verana Health analysis of American Academy of Ophthalmology IRIS®Registry presented in a late-breaking oral sessionReal-world clinical data show significant disease progression over a two-year period in more than 69,000 patients with GA, highlighting the urgent need for treatmentPatients were nearly three times more likely to develop new onset wet age-related macular degeneration (AMD) in an eye with GA when wet AMD had already been detected in the contralateral eyeWALTHAM, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced findings from the largest retrospective database study in geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The analysis of the American Academy of Ophthalmology...

KING OF PRUSSIA, Pa., Nov. 13, 2020 (GLOBE NEWSWIRE) — Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks used in entertainment, toy and educational products as well as in document and product authentication technologies to combat fraud, today announced results for its third quarter ended September 30, 2020 (Q3’20). Nocopi’s SEC filings are available here, https://bit.ly/35gTldxNocopi Chairman and CEO Michael Feinstein, commented, “Nocopi achieved another quarter of double digit revenue growth driven principally by growing demand for our specialty ink technologies used in toy and entertainment products. Specialty ink sales reached the second highest level in recent periods during the third quarter as our entertainment customers ramped production activity in anticipation of the holiday selling season....

IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced follow-up results of the first 230 patients enrolled in its FLASH study.  FLASH is a real world registry to study the FlowTriever system in intermediate- and high-risk pulmonary embolism (“PE”) patients.  The results were strongly positive.  Just one death (0.4%) was reported at 30 days.  By contrast, the national PERT Consortium® Quality Database recently showed 30-day mortality rates of 25.9% and 6.1% for high- and intermediate-risk PE patients.  In addition, the FLASH Registry showed a readmission rate of 6.7%, compared to the nearly 25% readmission rate shown in the PERT...